Sterne Kessler’s Tim Shea and Matthew Smith hosted an insightful webinar on the evolving U.S. biosimilar landscape. Topics included:

  • The current state of the U.S. biosimilar industry
  • Recent legal developments affecting U.S. biosimilars
  • Key regulatory updates and trends for 2026

Our presenters offered practical guidance on the legal and regulatory developments shaping biosimilar strategy.

Continuing Legal Education Credits

General CLE credit is pending for VA, CA, TX, NY, and IL.

Related Professionals

Related Industries